Among psychotropic medications prescribed to children and adolescents, antipsychotics have great potential for overuse. These drugs are often prescribed for aggressive or impulsive behaviors rather than psychosis and are associated with patient harms in a developing brain. The workgroup met from January to November 2016 to recommends strategies to improve the appropriateness of antipsychotic drug prescribing to pediatric patients supported by behavioral health service organized by the following focus areas:
- Conduct initial medical and psychological evaluation using appropriate assessment.
- Ensure that the patient and family has access to comprehensive, family-centered psychosocial care whether within the primary care setting through integrated behavioral health care or through a supported referral.
- Use evidence-based, best practice antipsychotic prescribing recommendations such as from the American Academy of Child and Adolescent Psychiatry.
- If antipsychotics are prescribed, manage side effects including monitoring for changes in weight blood glucose (HgA1C), cholesterol, and other metabolic changes (baseline and at regular intervals).
|Shelley Dooley||Parent Advocate|
|Nalini Gupta, MD||Pediatrician||Developmental and Behavioral Pediatrics
Providence Health and Services
|Robert Hilt, MD||Director, Community Leadership; Director of Partnership Access Line||Seattle Children’s|
|Paula Lozano, MD, MPH (Chair)||Medical Director, Research and Translation||Group Health Cooperative|
|Liz Pechous, PhD||Clinical Director||ICARD, PLLC|
|Robert Penfold, PhD||Co-investigator, Mental Health Research Network||Group Health Research Institute|
|James Polo, MD, MBA||Chief Medical Officer||Western State Hospital|
|David Testerman, PharmD||Pharmacy Director||Amerigroup|
|Mark Stein, PhD, ABPP||Director of ADHD and Related Disorders||Seattle Children’s|
|Donna Sullivan, PharmD, MS||Chief Pharmacy Officer||Washington Health Care Authority|